Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer.
Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, Juan T, Sikorski R, Suggs S, Radinsky R, Patterson SD, Chang DD.
Amado RG, et al. Among authors: freeman dj.
J Clin Oncol. 2023 Jun 20;41(18):3278-3286. doi: 10.1200/JCO.22.02758.
J Clin Oncol. 2023.
PMID: 37315390